<DOC>
	<DOC>NCT00644488</DOC>
	<brief_summary>The purpose of this clinical study is to assess the safety and tolerability of BMS-641988 once daily orally in Japanese patients with castration resistant prostate cancer</brief_summary>
	<brief_title>A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients with castrationresistant prostate cancer and serum testosterone â‰¤50 ng/dL progressive to current therapy who satisfy the inclusion and exclusion criteria</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>